Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
The Oncologist|February 1, 2011
New developments in hormone receptor-positive diseaseMartine J Piccart-GebhartThe Oncologist|December 9, 2010
New developments in hormone receptor-positive diseaseMartine J Piccart-GebhartEuropean Journal of Cancer (Oxford, England : 1990)|June 30, 2006
Adjuvant trastuzumab therapy for HER2-overexpressing breast cancer: what we know and what we still need to learnMartine J Piccart-GebhartClinical Breast Cancer|September 3, 2005
The evolving role of aromatase inhibitors in adjuvant breast cancer therapyI Craig Henderson, Martine J Piccart-GebhartCurrent Opinion in Oncology|July 14, 2009
Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancerPhilippe L Bedard, Martine J Piccart-GebhartClinical Breast Cancer|January 23, 2009
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancerPhilippe L Bedard, Martine J Piccart-GebhartClinical Advances in Hematology & Oncology : H&O|November 6, 2007
Trastuzumab for early breast cancer: current status and future directionsPhuong Dinh, Evandro de Azambuja, Martine J Piccart-GebhartJournal of Mammary Gland Biology and Neoplasia|March 5, 2009
Stemming resistance to HER-2 targeted therapyPhilippe L Bedard, Fatima Cardoso, Martine J Piccart-GebhartNature Reviews. Clinical Oncology|December 10, 2009
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancerPhilippe L Bedard, Angelo Di Leo, Martine J Piccart-GebhartCritical Reviews in Oncology/Hematology|March 18, 2008
New therapies for ovarian cancer: cytotoxics and molecularly targeted agentsPhuong Dinh, Paul Harnett, Martine J Piccart-Gebhart, et al.Pageof 5